Evidence map›Paper›PMID 26637561›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2016

Activation of mitochondrial calpain and increased cardiac injury: beyond AIF release.

Jeremy Thompson, Ying Hu, Edward J Lesnefsky, Qun Chen

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jeremy ThompsonDivision of Cardiology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia;
Ying HuDivision of Cardiology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia;
Edward J LesnefskyDivision of Cardiology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia; Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, Virginia; Department of Physiology and Biophysics, Virginia Commonwealth University, Richmond, Virginia; and McGuire Veterans Affairs Medical Center, Richmond, Virginia.
Qun ChenDivision of Cardiology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia; Qun.chen@vcuhealth.org.ORCID http://orcid.org/0000-0001-5683-7844
Virginia Commonwealth University · US

Funding

Center for Clinical and Translational ResearchUL1TR000058 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI MOELLER, FREDERICK GERARD · 2012 to 2015
$12.5M
BLRD VA I01 BX001355NCATS NIH HHS UL1 TR000058NCATS NIH HHS UL1TR000058
6 · The paper itself

Abstract

Calpain 1 (CPN1) is a ubiquitous cysteine protease that exists in both cytosol and cardiac mitochondria. Mitochondrial CPN1 (mit-CPN1) is located in the intermembrane space and matrix. Activation of mit-CPN1 within the intermembrane space increases cardiac injury by releasing apoptosis-inducing factor from mitochondria during ischemia-reperfusion (IR). We asked if activation of mit-CPN1 is involved in mitochondrial injury during IR. MDL-28170 (MDL) was used to inhibit CPN1 in buffer-perfused hearts following 25-min ischemia and 30-min reperfusion. MDL treatment decreased the release of lactate dehydrogenase into coronary effluent compared with untreated hearts, indicating that inhibition of CPN1 decreases cardiac injury. MDL also prevented the cleavage of spectrin (a substrate of CPN1) in cytosol during IR, supporting that MDL treatment decreased cytosolic calpain activation. In addition, MDL markedly improved calcium retention capacity compared with untreated heart, suggesting that MDL treatment decreases mitochondrial permeability transition pore opening. In addition, we found that IR led to decreased complex I activity, whereas inhibition of mit-CPN1 using MDL protected complex I. Pyruvate dehydrogenase content was decreased following IR. However, pyruvate dehydrogenase content was preserved in MDL-treated mitochondria. Taken together, MDL treatment decreased cardiac injury during IR by inhibiting both cytosolic and mit-CPN1. Activation of mit-CPN1 increases cardiac injury during IR by sensitizing mitochondrial permeability transition pore opening and impairing mitochondrial metabolism through damage of complex I.

Indexed as

AnimalsApoptosis Inducing FactorCalciumCalpainCysteine Proteinase InhibitorsCytosolDipeptidesElectron Transport Complex IHeartL-Lactate DehydrogenaseMaleMiceMice, Inbred C57BLMitochondria, HeartMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreAIFM1 protein, mouseApoptosis Inducing FactorCalciumCalpaincalpain inhibitor IIICapn1 protein, mouseCysteine Proteinase InhibitorsDipeptidesElectron Transport Complex IL-Lactate DehydrogenaseMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreSpectrincalciumcomplex ImitochondriaMPTPPDH

Identifiers

PMID26637561
PMCPMC4796621
OpenAlexW2264085998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.